Jazz Pharmaceuticals plc - SHS USD (JAZZ)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SHS USD
Shares, excl. options Q1 2024
57.7 M
Holdings value Q1 2024
$6.94 B
Value change Q1 2024
+$195 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
459
Number of buys Q1 2024
9
Number of sells Q1 2024
-9
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.004%
CUSIP
G50871105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 38.1 K $4.07 M -$11.7 M $106.73 22
2024 Q1 57.8 M $6.96 B +$195 M $120.42 462
2023 Q4 55.2 M $6.79 B -$15.3 M $123.00 483
2023 Q3 55.3 M $7.16 B -$26.7 M $129.44 474
2023 Q2 55.3 M $6.86 B -$39.3 M $123.97 459
2023 Q1 55.6 M $8.13 B -$7.3 M $146.33 456
2022 Q4 55.9 M $8.9 B -$102 M $159.31 476
2022 Q3 56.6 M $7.55 B -$101 M $133.29 444
2022 Q2 55.6 M $8.67 B +$131 M $156.01 442
2022 Q1 56.5 M $8.8 B -$108 M $155.67 434
2021 Q4 57.4 M $7.32 B +$27.2 M $127.40 423
2021 Q3 56.4 M $7.34 B -$101 M $130.21 424
2021 Q2 57 M $10.1 B +$781 M $177.64 479
2021 Q1 52.6 M $8.65 B +$71.8 M $164.37 434
2020 Q4 52.3 M $8.63 B -$302 M $165.05 421
2020 Q3 54.5 M $7.76 B +$372 M $142.59 378
2020 Q2 52 M $5.73 B +$271 M $110.34 371
2020 Q1 49.2 M $4.9 B -$263 M $99.74 388
2019 Q4 51.7 M $7.72 B +$201 M $149.28 433
2019 Q3 48.6 M $6.23 B +$106 M $128.14 395
2019 Q2 50 M $7.11 B +$216 M $142.56 404
2019 Q1 51 M $7.29 B -$216 M $142.95 413
2018 Q4 52.9 M $6.55 B -$433 M $123.96 408
2018 Q3 55.2 M $9.27 B -$145 M $168.13 396
2018 Q2 56.1 M $9.66 B +$432 M $172.30 377
2018 Q1 53.7 M $8.09 B -$76.3 M $150.99 320
2017 Q4 54.9 M $7.3 B -$66.2 M $134.65 315
2017 Q3 54.5 M $7.97 B +$210 M $146.25 301
2017 Q2 53 M $8.25 B +$381 M $155.50 314
2017 Q1 51.8 M $7.52 B +$546 M $145.13 300
2016 Q4 51.9 M $5.66 B -$184 M $109.03 288
2016 Q3 52.2 M $6.34 B -$44.3 M $121.48 315
2016 Q2 53.8 M $7.6 B -$56.6 M $141.31 356
2016 Q1 54.4 M $7.1 B -$237 M $130.55 329
2015 Q4 56.1 M $7.89 B -$26.5 M $140.56 338
2015 Q3 55.2 M $7.33 B +$36.6 M $132.81 352
2015 Q2 55.9 M $9.84 B +$576 M $176.07 368
2015 Q1 50.7 M $8.77 B -$344 M $172.79 353
2014 Q4 54.3 M $8.89 B +$176 M $163.73 354
2014 Q3 53.2 M $8.54 B +$343 M $160.56 324
2014 Q2 50.5 M $7.42 B +$48.1 M $147.01 304
2014 Q1 50.5 M $7 B +$314 M $138.68 314